Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DUPONT DE NEMOURS, INC. (DD)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 3
  • 1 comments

DuPont Announces Regular Quarterly Dividend on Common Stock

Market reaction Comment Full text

QUALCOMM INC/DE (QCOM)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 4
  • 1 comments

Qualcomm Accelerates Diversification with Comprehensive Strategy for Data Center and Sees Multiple Inflection Points Over the Next 3 to 5 Years

Market reaction Comment Full text

CURRENC GROUP INC. (CURR)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 3
  • 1 comments

Currenc Group Executes Strategic Restructuring of Indonesian WalletKu Subsidiary to Refocus on High-Growth AI & Web3 Roadmap

Market reaction Comment Full text

MICWARE CO., LTD. (MWC)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 1
  • 1 comments

Micware Co., Ltd. to Host Fiscal Year 2026 Earnings Call on July 1, 2026

Market reaction Comment Full text

MORGAN STANLEY (MS)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 5
  • 1 comments

Morgan Stanley Announces a Dividend Increase of 15 Cents to $1.15 Per Share and the Reauthorization of a $20 Billion Multi-Year Common Equity Share Repurchase Program

Market reaction Comment Full text

BANKUNITED, INC. (BKU)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 3
  • 1 comments

BankUnited, Inc. Announces Quarterly Dividend

Market reaction Comment Full text

Dupont De Nemours Inc (DD)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 2
  • 1 comments

DuPont Announces Regular Quarterly Dividend on Common Stock

Market reaction Comment Full text

GRANITE CONSTRUCTION INC (GVA)

  • Business News
  • June 24, 2026, 20:30 UTC
  • 4
  • 1 comments

Granite Awarded West Davis Corridor Expansion Project in Utah

Market reaction Comment Full text

Gilead Sciences Inc (GILD)

  • Business News
  • June 24, 2026, 20:29 UTC
  • 4
  • 1 comments

Gilead - U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer

Market reaction Comment Full text

GILEAD SCIENCES, INC. (GILD)

  • Business News
  • June 24, 2026, 20:29 UTC
  • 4
  • 1 comments

U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer

Market reaction Comment Full text
  • Previous
  • 3310
  • 3311
  • 3312
  • 3313
  • 3314
  • Next

Search

News categories

  • Technical Exchange News(14471)
  • Event(6229)
  • SEC News(381497)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(232738)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin